Literature DB >> 12527809

Norepinephrine release from the ischemic heart is greatly enhanced in mice lacking histamine H3 receptors.

Motohiro Koyama1, Nahid Seyedi, Wai-Ping Fung-Leung, Timothy W Lovenberg, Roberto Levi.   

Abstract

We previously reported that histamine H(3) receptors (H(3)Rs) are present in cardiac sympathetic nerve endings (cSNE) of animals and humans, where they attenuate norepinephrine (NE) release in normal and hyperadrenergic states, such as myocardial ischemia. The recent creation of a transgenic line of mice lacking H(3)R provided us with the opportunity to assess the relevance of H(3)R in the ischemic heart. We isolated SNE from hearts of wild-type (H(3)R(+/+)) and knockout (H(3)R(-/-)) mice and found that basal NE release from H(3)R(-/-) cSNE was approximately 60% greater than that from H(3)R(+/+) cSNE. NE exocytosis evoked by K(+)-induced depolarization of cSNE from H(3)R(+/+) mice was attenuated by activation of either H(3)R or adenosine A(1) receptors (A(1)R). In contrast, NE release from cSNE of H(3)R(-/-) was unaffected by H(3)R agonists, but it was still attenuated by A(1)R activation. When isolated mouse hearts were subjected to ischemia for 20 min, NE overflow into the coronaries was 2-fold greater in the H(3)R(-/-) hearts than in those from H(3)R(+/+) mice. Furthermore, whereas stimulation of H(3)R or A(1)R reduced ischemic NE overflow from H(3)R(+/+) hearts by 50%, only A(1)R, but not H(3)R activation, reduced NE release in H(3)R(-/-). Our data demonstrate that NE release from cSNE can be modulated by various heteroinhibitory receptors (e.g., H(3)R and A(1)R) and that H(3)Rs are particularly important in modulating NE release in myocardial ischemia. Inasmuch as excessive NE release is clinically recognized as a major cause of arrhythmic cardiac dysfunction, our findings reveal a significant cardioprotective role of H(3)R on cSNE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527809     DOI: 10.1124/mol.63.2.378

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.

Authors:  Narumi Hashikawa-Hobara; Noel Yan-Ki Chan; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2011-10-19       Impact factor: 4.030

2.  Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia.

Authors:  Gonghao He; Jing Hu; Teng Li; Xue Ma; Jingru Meng; Min Jia; Jun Lu; Hiroshi Ohtsu; Zhong Chen; Xiaoxing Luo
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 3.  Cardiac GPCRs: GPCR signaling in healthy and failing hearts.

Authors:  Natasha C Salazar; Juhsien Chen; Howard A Rockman
Journal:  Biochim Biophys Acta       Date:  2007-02-20

Review 4.  Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.

Authors:  Alicia C Reid; Jacqueline A Brazin; Christopher Morrey; Randi B Silver; Roberto Levi
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

5.  The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons.

Authors:  Federico Corti; Kim E Olson; Aaron J Marcus; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2011-02-16       Impact factor: 4.030

6.  Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.

Authors:  Christina J Mackins; Seiichiro Kano; Nahid Seyedi; Ulrich Schäfer; Alicia C Reid; Takuji Machida; Randi B Silver; Roberto Levi
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

7.  Central endogenous histamine modulates sympathetic outflow through H3 receptors in the conscious rabbit.

Authors:  Julian Charles; James A Angus; Christine E Wright
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

8.  A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H₃ receptor stably expressed in CHO-K1 cells.

Authors:  Cecilia Flores-Clemente; Angélica Osorio-Espinoza; Juan Escamilla-Sánchez; Rob Leurs; Juan-Manuel Arias; José-Antonio Arias-Montaño
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Cardioprotective effect of histamine H3-receptor activation: pivotal role of G beta gamma-dependent inhibition of voltage-operated Ca2+ channels.

Authors:  Christopher Morrey; Rima Estephan; Geoffrey W Abbott; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2008-06-03       Impact factor: 4.030

10.  Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation.

Authors:  Silvia Aldi; Ken-ichi Takano; Kengo Tomita; Kenichiro Koda; Noel Y-K Chan; Alice Marino; Mariselis Salazar-Rodriguez; Robin L Thurmond; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2014-04-02       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.